Nicast is seeking medical device distributors for its unique AVflo™ vascular access grafts. The potential distributor must cover vascular access for hemodialysis (not for chemotherapy).
AVflo™ is a CE-marked, nanofiber graft for vascular access in hemodialysis providing initiation of dialysis within 24 hours, immediate self-sealing and minimal infection risk. It is available in the EU market, several Asian countries and Israel.
Nicast is an innovative nanotechnology company with over a dozen international patents for its development of implantable medical devices made of electrospun polymer nanofabrics. The nanofabric structure mimics the body’s extracellular matrix and is an excellent medium for tissue integration. Nicast is a pioneer in the development of medical devices made of electrospun polymer nanofabrics.